{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:55:37Z","timestamp":1761486937243},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2003,1,1]]},"DOI":"10.1038\/sj.bmt.1703778","type":"journal-article","created":{"date-parts":[[2003,3,5]],"date-time":"2003-03-05T16:58:40Z","timestamp":1046883520000},"page":"23-29","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrow"],"prefix":"10.1038","volume":"31","author":[{"given":"L","family":"Garderet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Labopin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N C","family":"Gorin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Polge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Fouillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G E","family":"Ehninger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Ringden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Finke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Tura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Frassoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,1,21]]},"reference":[{"key":"BF1703778_CR1","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1200\/JCO.1995.13.10.2547","volume":"13","author":"W Bensinger","year":"1995","unstructured":"Bensinger W, Appelbaum F, Rowley S et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995; 13: 2547\u20132555.","journal-title":"J Clin Oncol"},{"key":"BF1703778_CR2","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1182\/blood.V85.6.1655.bloodjournal8561655","volume":"85","author":"W Bensinger","year":"1995","unstructured":"Bensinger W, Weaver CH, Appelbaum FR et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995; 85: 1655\u20131658.","journal-title":"Blood"},{"key":"BF1703778_CR3","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1182\/blood.V85.6.1659.bloodjournal8561659","volume":"85","author":"M Korbling","year":"1995","unstructured":"Korbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukaemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995; 85: 1659\u20131665.","journal-title":"Blood"},{"key":"BF1703778_CR4","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1182\/blood.V85.6.1666.bloodjournal8561666","volume":"85","author":"N Schmitz","year":"1995","unstructured":"Schmitz N, Dreger P, Suttorp M et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 1995; 85: 1666\u20131672.","journal-title":"Blood"},{"key":"BF1703778_CR5","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1200\/JCO.2000.18.3.537","volume":"18","author":"D Blaise","year":"2000","unstructured":"Blaise D, Kuentz M, Fortanier C et al. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early stage leukaemia: a report from the Soci\u00e9t\u00e9 Francaise de Greffe de Moelle. J Clin Oncol 2000; 18: 537\u2013546.","journal-title":"J Clin Oncol"},{"key":"BF1703778_CR6","first-page":"3702","volume":"95","author":"R Champlin","year":"2000","unstructured":"Champlin R, Schmitz N, Horowitz M et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. Blood 2000; 95: 3702\u20133709.","journal-title":"Blood"},{"key":"BF1703778_CR7","unstructured":"Schmitz N, Beksac M, Hasenclever D et al. A randomised study from the European group for blood and marrow transplantation comparing allogeneic transplantation of filgrastim-mobilised peripheral blood progenitor cells with bone marrow transplantation in 350 patients with leukaemia. Blood 2000; 96: abstract 2068."},{"key":"BF1703778_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1056\/NEJM200101183440303","volume":"344","author":"W Bensinger","year":"2001","unstructured":"Bensinger W, Martin P, Storer B et al. Transplantation of bone marrow as compared with peripheral blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001; 344: 175\u2013181.","journal-title":"N Engl J Med"},{"key":"BF1703778_CR9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1182\/blood.V94.2.455","volume":"94","author":"O Ringden","year":"1999","unstructured":"Ringden O, Remberger M, Runde V et al. A peripheral blood stem cell transplantation from unrelated donors: a comparison with bone marrow transplantation. Blood 1999; 94: 455\u2013464.","journal-title":"Blood"},{"key":"BF1703778_CR10","first-page":"839","volume":"85","author":"M Bornhauser","year":"2000","unstructured":"Bornhauser M, Theuser C, Soucek S et al. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis. Haematologica 2000; 85: 839\u2013847.","journal-title":"Haematologica"},{"key":"BF1703778_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/sj.bmt.1702734","volume":"27","author":"IW Blau","year":"2001","unstructured":"Blau IW, Basara N, Lentini G et al. Feasibility and safety of peripheral blood stem cell transplantation from unrelated donors: results of a single center study. Bone Marrow Transplant 2001; 27: 27\u201333.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703778_CR12","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1182\/blood.V98.6.1739","volume":"98","author":"M Remberger","year":"2001","unstructured":"Remberger M, Ringden O, Blau I et al. No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors. Blood 2001; 98: 1739\u20131745.","journal-title":"Blood"},{"key":"BF1703778_CR13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1182\/blood.V94.2.381","volume":"94","author":"FR Appelbaum","year":"1999","unstructured":"Appelbaum FR. Choosing the source of stem cells for allogeneic transplantation: no longer a peripheral issue. Blood 1999; 94: 381\u2013383.","journal-title":"Blood"},{"key":"BF1703778_CR14","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/00062752-200011000-00004","volume":"7","author":"A Bacigalupo","year":"2000","unstructured":"Bacigalupo A, Frassoni F, Van Lint MT. Bone marrow or peripheral blood as a source of stem cells for allogeneic transplants. Curr Opin Hematol 2000; 7: 343\u2013347.","journal-title":"Curr Opin Hematol"},{"key":"BF1703778_CR15","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1182\/blood.V90.12.4705","volume":"90","author":"J Storek","year":"1997","unstructured":"Storek J, Gooley T, Siadak M et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood 1997; 90: 4705\u20134709.","journal-title":"Blood"},{"key":"BF1703778_CR16","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1182\/blood.V89.11.4226","volume":"89","author":"J Sierra","year":"1997","unstructured":"Sierra J, Storer B, Hansen J et al. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukaemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood 1997; 89: 4226\u20134235.","journal-title":"Blood"},{"key":"BF1703778_CR17","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/sj.bmt.1701983","volume":"24","author":"D Przepiorka","year":"1999","unstructured":"Przepiorka D, Khouri I, Ippoliti C et al. Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation. Bone Marrow Transplant 1999; 24: 763\u2013768.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703778_CR18","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825\u2013828.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703778_CR19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457\u2013481.","journal-title":"J Am Stat Assoc"},{"key":"BF1703778_CR20","first-page":"187","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR. Regression models and life tables. J R Stat Soc 1972; 34: 187\u2013202.","journal-title":"J R Stat Soc"},{"key":"BF1703778_CR21","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/sj.bmt.1701234","volume":"21","author":"N Schmitz","year":"1998","unstructured":"Schmitz N, Bacigalupo A, Hasenclever D et al. Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1998; 21: 995\u20131003.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703778_CR22","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1056\/NEJM197905103001902","volume":"300","author":"PL Weiden","year":"1979","unstructured":"Weiden PL, Flournoy N, Thomas ED et al. Anti-leukaemic effect of graft-versus-host disease in human recipients of allogeneic marrow grafts. N Engl J Med 1979; 300: 1068\u20131073.","journal-title":"N Engl J Med"},{"key":"BF1703778_CR23","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/blood.V94.2.384","volume":"94","author":"AH Elmagacli","year":"1999","unstructured":"Elmagacli AH, Beelen DW, Opalka B et al. The risk of residual molecular and cytogenetic disease in patients with Philadelphia-chromosome positive first chronic phase chronic myelogenous leukaemia is reduced after transplantation of allogeneic peripheral blood stem cells compared with bone marrow. Blood 1999; 94: 384\u2013389.","journal-title":"Blood"},{"key":"BF1703778_CR24","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1365-2141.1994.tb08321.x","volume":"87","author":"P Dreger","year":"1994","unstructured":"Dreger P, Haferlach T, Eckstein V et al. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: Safety, kinetics of mobilization, and composition of the graft. Br J Haematol 1994; 87: 609\u2013613.","journal-title":"Br J Haematol"},{"key":"BF1703778_CR25","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1089\/152581602753658466","volume":"11","author":"NC Gorin","year":"2002","unstructured":"Gorin NC. Increased risk of lethal graft versus host disease-like syndrome after transplantation into NOD\/SCID mice of human mobilized peripheral blood stem cells as compared to bone marrow or cord blood. J Hematother Stem Cell Res 2002; 11: 277\u2013292.","journal-title":"J Hematother Stem Cell Res"},{"key":"BF1703778_CR26","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1182\/blood.V76.12.2462.2462","volume":"76","author":"HJ Kolb","year":"1990","unstructured":"Kolb HJ, Mittermueller J, Clemm C et al. Donor leukocyte transfusion for treatment of recurrent chronic myelogenous leukaemia in marrow transplant patients. Blood 1990; 76: 2462\u20132465.","journal-title":"Blood"},{"key":"BF1703778_CR27","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","volume":"91","author":"S Slavin","year":"1998","unstructured":"Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem-cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and non-malignant hematologic diseases. Blood 1998; 91: 756\u2013763.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1703778","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703778.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703778.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:24:15Z","timestamp":1648077855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1703778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1,1]]}},"alternative-id":["BF1703778"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1703778","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1,1]]},"assertion":[{"value":"10 April 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}